Brochure
How Can Smarter Sample Collection Empower Patient-Centric Trials?
Decentralised Sample Collection: Enabling Patient-Centric Trials with Operational Integrity
Sep 24, 2025

Pharmaceutical sponsors and clinical sites are increasingly adopting decentralized sample collection models—such as home nursing visits—to reduce patient burden and improve trial accessibility. These models enhance recruitment and retention while maintaining regulatory compliance and Principal Investigator (PI) oversight.

IQVIA's decentralized clinical trial (DCT) framework ensures that remote procedures meet the same safety and quality standards as in-clinic visits. Each protocol undergoes feasibility review, and credentialed nurses are supported with verified training records and structured delegation. This safeguards patient safety and ensures Good Clinical Practice (GCP) compliance across all geographies.

Home visits empower patients while preserving PI discretion. Nurses apply clinical judgement during assessments, but adverse event classification remains with the PI—ensuring data consistency. IQVIA also coordinates with local laboratories to align sample handling with lab-specific requirements, preserving data integrity and operational flow.

This flexible model supports personalized care pathways. Patients may opt for home visits, but the PI retains authority to adapt care based on evolving clinical needs.

Download the full article to learn how IQVIA's decentralized solutions can be tailored to your protocol and patient population.

Contact IQVIA to explore custom strategies for your next trial.

Contact Us